Bay Street News, November 8th, 2018

VANCOUVER, B.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — Glance Technologies Inc. (“Glance” or the “Company”) (CSE:GET.CN) (OTCQB:GLNNF) (FKT:GJT) is pleased […]

VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” […]

MADISON, Wis., Nov. 08, 2018 (GLOBE NEWSWIRE) — Madison Covered Call & Equity Strategy Fund (NYSE:MCN) (the “Fund”) announced today […]

SAN JOSE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) announced that it has entered into an […]

Basking Ridge, New Jersey, Nov. 08, 2018 (GLOBE NEWSWIRE) — Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors BASKING […]

NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, […]

MINNEAPOLIS, Nov. 08, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on […]

BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing […]

BEDFORD, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that […]

—Seasoned Pharmaceutical Executive Elizabeth McKee Anderson Appointed as New Director— —Donald Hayden, Jr. Steps Down as Chairman After 13 Years […]